文献速递头颈外科

可生物吸收标记物用于头颈癌瘤床边缘标记的可行性研究

A Bioresorbable Fiducial for Head and Neck Cancer.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-05-19

该研究评估一种新型可生物吸收标记物(L-丙交酯与ε-己内酯)用于头颈癌瘤床边缘标记的可行性。在橙子和苹果酱中进行CT及T1、T2、PD加权MRI采集,图像显示标记物边界清晰、无邻近伪影。初步结果表明该标记物在颅底或颈部阳性边缘术中标记具有临床实用性。

要点

  • 可生物吸收标记物在CT和MRI上边界清晰,无邻近伪影。
  • 标记物在CT和MRI上呈类似空气的表现,周围介质呈液体样外观。
  • 初步图像支持其用于颅底或颈部阳性边缘术中标记以指导治疗和监测。

核心结论

  • 可生物吸收标记物在CT和MRI上显示良好 delineation 且无邻近伪影,初步支持其用于头颈癌瘤床边缘术中标记。

研究设计与样本

  • 可行性测试研究,将标记物(L-丙交酯和ε-己内酯)置于橙子中进行CT采集,置于苹果酱中进行T1、T2和PD加权MRI采集,使用常规临床参数。

主要发现

  • CT和MRI图像显示标记物所有边缘均清晰可见,无邻近伪影。
  • 标记物在CT和MRI上表现类似空气,周围介质呈液体样外观。

临床怎么用

  • 计划放疗时手术床外观不应在标记物附近产生伪影,且标记物本身不应有固有伪影。
  • 该标记物可用于颅底或颈部阳性边缘的术中标记,以指导未来治疗和监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aim to evaluate a novel bioresorbable fiducial for marking tumor bed margins in head and neck cancers (HNCs) to improve upon current use of nonresorbable materials. A feasibility test was done placing the marker (L-lactide and ε-caprolactone) in an orange for computed tomography (CT) and applesauce for T1-, T2-, and PD-weighted magnetic resonance imaging (MRI) image acquisition, using routine clinical parameters. The resulting CT and MRI images showed excellent delineation of the marker with all of its margins well seen without adjacent artifact. The marker appeared similar to air on CT and MRI, surrounded by fluid-like appearance of the medium. Surgical bed appearance when radiotherapy is planned should not produce any artifact near the marker, and there should be no inherent marker-related artifact. These pilot CT and MR images show clinical utility for intraoperative marking of positive margins in the skull base or neck to guide future treatment and monitoring.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Fischman V, Ivanovic V, Jalisi S, et al. A Bioresorbable Fiducial for Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020. PMID: 32427505. doi:10.1177/0194599820921864

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。